WeVote
Log In

Bill

Bill

S 83

Postsecondary closings

2025-2026 Regular Session Introduced by Josh Kimbrell and 1 co-sponsor

Authorizes vertical integration, imposes initial capital requirements, caps license fees at 1,000 (social equity exempt), and expands card holder definitions to include out-of-stat

Referred to Committee on Education
0
WeVote Research Nonpartisan
Bill Summary · S 83

Summary — S.83 (2025): "An Act to modernize Massachusetts medical marijuana program"

Note: The bill text filed as Senate No. 83 (docket 2048) and introduced by Sen. Adam Gómez updates Chapter 94I (Massachusetts medical marijuana law). (The header/title in your prompt referencing "larceny by cyber extortion" appears to be an error and is not reflected in the bill text.)

Purpose

To amend and modernize the Commonwealth’s medical marijuana statute (G.L. c.94I) by (1) updating terminology, (2) clarifying who may be sold medical-use marijuana, (3) authorizing the Cannabis Control Commission to set licensing conditions (including vertical integration and capital requirements), and (4) capping certain license fees while exempting social equity businesses.

Key provisions (by section)

  • Section 1 — Definition change:

    • Replaces the definition of “Card holder” to mean a registered qualifying patient, personal caregiver, or agent of a medical marijuana treatment center holding a valid Massachusetts registration card, or an individual who possesses a valid patient registration for medical-use marijuana issued by another U.S. jurisdiction (explicitly recognizes out‑of‑state patient registrations).

  • Sections 2–4 — Terminology and sales authorization:

    • Clarifies that only entities “licensed and authorized by the Commission to dispense or deliver medical use marijuana” may sell to a “card holder.”
    • Replaces multiple references to “qualifying patient” / “personal caregiver” / “qualifying patients or their personal caregivers” with the unified term “card holder.”

  • Sections 5–8 — Licensing conditions and capital requirements:

    • Technical edits to allow insertion of new clauses.
    • New §6(iv): The Commission may require medical use marijuana licensees to simultaneously cultivate, process, and dispense medical marijuana as a condition of licensing (i.e., require vertical integration).
    • New §6(v): The Commission may require demonstration of initial capital of $500,000 for a first (initial) license application and $400,000 for subsequent license applications.

  • Section 9 — License fees:

    • Amends fee language to cap license fees for medical marijuana treatment centers at no more than $1,000 each.
    • Exempts “social equity business,” as defined in Chapter 94G, from these fees.

  • Section 10 — Enforcement cross-reference:

    • Adds Chapter 94I to the enforcement language in G.L. c.94G §14(b), making enforcement mechanisms in 94G applicable to 94I where specified.

Who is affected

  • Prospective and existing medical marijuana treatment centers (license holders and applicants): may face new vertical-integration requirements and capital thresholds; fee caps reduce fee burden but social equity businesses receive explicit fee exemption.
  • Registered patients and caregivers (card holders), including out‑of‑state registered patients: definition broadened to explicitly include non‑Massachusetts registrations.
  • Cannabis Control Commission: given clearer authority to condition licensure on integration and capital requirements; receives statutory edits referencing enforcement.
  • Social equity businesses: exempted from the treatment center license fee cap.

Procedural status / timeline (selected)

  • Introduced in Senate: 2025-01-14 (read twice; referred to Committee on the Judiciary; docket filed 1/17/2025).
  • Referred to Committee on Cannabis Policy: 2025-02-27.
  • Advanced to third reading and passed Senate: late February–March 2025 (passed Senate 03/03/2025).
  • Delivered to House / referred to Codes (House committee): 03/03/2025.
  • Hearing scheduled (Cannabis Policy): 04/09/2025, 10:30 AM (location B-1).

Implications / considerations

  • The vertical-integration and capital requirements could raise barriers to entry (favoring larger, better‑capitalized operators) unless the Commission implements flexibility or carve-outs.
  • The fee cap and social equity fee exemption reduce near-term license costs, potentially offsetting some capital burdens for eligible entities.
  • Recognizing out‑of‑state patient registrations could expand the effective patient base that can legally obtain medical marijuana in Massachusetts, depending on Commission rules and operational policies.
  • Much of the substantive impact will depend on how the Cannabis Control Commission exercises the new or clarified authorities (regulatory implementation and rulemaking).

If you want, I can:
- Produce a side‑by‑side comparison of current statutory text vs. the proposed changes, or
- Draft questions/comments a committee might raise about the bill’s regulatory and equity impacts.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.